Literature DB >> 7625496

Redefining the goals of national drug policy: recommendations from a working group.

P Reuter1, J P Caulkins.   

Abstract

This paper discusses what the goals of national drug policy have been and suggests an alternative set of goals. The past emphasis on use reduction is found wanting. Total harm related to drugs can be viewed as the product of use and harm per use. Thus, reducing use usually serves to reduce harm. However, in some cases, use reduction programs may increase harm per use so much that they increase overall harm even as they succeed in reducing use. Hence, use reduction goals can be usefully augmented with the explicit objective of reducing the total harm created by the production, distribution, consumption, and control of drugs. Numerous programmatic recommendations flow from this approach.

Mesh:

Substances:

Year:  1995        PMID: 7625496      PMCID: PMC1615810          DOI: 10.2105/ajph.85.8_pt_1.1059

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  5 in total

Review 1.  Needle exchange or needless exchange? The state of the debate.

Authors:  E H Kaplan
Journal:  Infect Agents Dis       Date:  1992-04

2.  Dutch policy on the management of drug-related problems.

Authors:  E L Engelsman
Journal:  Br J Addict       Date:  1989-02

3.  Explaining the recent decline in marijuana use: differentiating the effects of perceived risks, disapproval, and general lifestyle factors.

Authors:  J G Bachman; L D Johnston; P M O'Malley; R H Humphrey
Journal:  J Health Soc Behav       Date:  1988-03

4.  A 24-year follow-up of California narcotics addicts.

Authors:  Y I Hser; D Anglin; K Powers
Journal:  Arch Gen Psychiatry       Date:  1993-07

5.  Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988.

Authors:  D P Rice; S Kelman; L S Miller
Journal:  Public Health Rep       Date:  1991 May-Jun       Impact factor: 2.792

  5 in total
  7 in total

1.  The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs.

Authors:  Kora DeBeck; Thomas Kerr; Calvin Lai; Jane Buxton; Julio Montaner; Evan Wood
Journal:  Am J Drug Alcohol Abuse       Date:  2011-08-11       Impact factor: 3.829

Review 2.  Globalisation of anti-doping: the reverse side of the medal.

Authors:  Bengt Kayser; Aaron C T Smith
Journal:  BMJ       Date:  2008-07-04

3.  Is a rational, national drug policy possible?

Authors:  J H Kilwein
Journal:  Am J Public Health       Date:  1996-01       Impact factor: 9.308

Review 4.  Recent advances in the treatment of opiate addiction.

Authors:  Paul J Fudala; George W Woody
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

5.  The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US.

Authors:  Mitchell Zeller; Dorothy Hatsukami
Journal:  Tob Control       Date:  2009-02-24       Impact factor: 7.552

6.  Tobacco Harm Reduction as a Path to Restore Trust in Tobacco Control.

Authors:  Tamar M J Antin; Geoffrey Hunt; Rachelle Annechino
Journal:  Int J Environ Res Public Health       Date:  2021-05-22       Impact factor: 3.390

Review 7.  Why the war on drugs in sport will never be won.

Authors:  Aaron C T Smith; Bob Stewart
Journal:  Harm Reduct J       Date:  2015-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.